Table 2 (A) Clinicopathological variables and miR-126 in tumor and stroma as predictors of disease-specific survival for colon cancer patients (univariate analyses, log-rank test, n = 452), (B) dichotomized miR-126 in tumor and stroma and their distribution over and correlation with clinicopathological variables (chi-square and Fisher’s exact tests).

From: High expression of microRNA-126 relates to favorable prognosis for colon cancer patients

 

A

B

N (%)

5 Year

Median

HR (95%CI)

 

miR126 in tumor

miR126 in stroma

P

Low

High

 

Low

High

P

Age

    

0.013

  

0.358

  

0.130

≤ 65

110 (24)

88

NA

1.00

 

78

30

 

89

20

 

> 65

342 (76)

76

NA

1.83 (1.21–2.77)

 

222

110

 

252

89

 

Gender

    

0.388

  

0.751

  

1.000

Female

243 (54)

78

NA

1.00

 

165

74

 

184

59

 

Male

209 (46)

81

NA

0.85 (0.58–1.23)

 

135

66

 

157

50

 

Weight_loss

    

0.012

  

0.092

  

0.621

 < 10%

248 (55)

82

NA

1.00

 

157

83

 

192

55

 

 ≥ 10%

94 (21)

68

NA

1.74 (1.06–2.87)

 

69

22

 

70

24

 

Missing

110 (24)

          

ECOG_status

    

0.424

  

0.997

  

0.993

0

237 (52)

82

NA

1.00

 

157

75

 

178

57

 

1

149 (33)

76

NA

1.31 (0.86–1.99)

 

98

45

 

113

36

 

2

54 (12)

74

NA

1.18 (0.62–2.28)

 

36

17

 

40

14

 

3

8 (2)

50

47

2.31 (0.31–16.98)

 

6

2

 

6

2

 

Missing

4 (1)

          

Site

    

0.951

  

0.824

  

0.700

Sigmoid

227 (50)

79

NA

1.00

 

152

69

 

171

56

 

Transversum

65 (14)

78

NA

0.94 (0.52–1.68)

 

45

19

 

47

18

 

Left

21 (5)

80

NA

1.15 (0.47–2.78)

 

14

5

 

18

3

 

Right

136 (30)

79

NA

1.09 (0.71–1.67)

 

87

46

 

102

32

 

Missing

3 (1)

          

pStage

    

 < 0.001

  

0.388

  

0.027

1

72 (16)

94

NA

1.00

 

46

25

 

53

19

 

2

219 (48)

89

NA

2.27 (1.35–3.81)

 

142

72

 

156

63

 

3

161 (36)

59

NA

8.04 (4.58–14.11)

 

112

43

 

132

27

 

Differentiation

    

 < 0.001

  

0.311

  

0.006

Well

36 (8)

89

NA

1.00

 

19

16

 

27

9

 

Moderate

329 (73)

78

NA

1.47 (0.76–2.82)

 

224

98

 

259

68

 

Poor

75 (17)

79

NA

1.45 (0.67–3.15)

 

49

22

 

48

27

 

Undifferentiated

4 (1)

25

10

11.34 (0.45–283.15)

 

3

1

 

1

3

 

Missing

8 (2)

          

Vasc+

    

 < 0.001

  

0.305

  

0.575

No

199 (44)

83

NA

1.00

 

121

69

 

151

48

 

Yes

19 (4)

45

30

5.22 (1.66–16.37)

 

14

4

 

15

3

 

Missing

234 (52)

          

Resection margins

    

0.005

  

0.519

  

0.630

0 mm

31 (7)

54

68

1.00

 

23

6

 

26

5

 

 < 1 mm

42 (9)

70

NA

0.56 (0.2–1.54)

 

31

11

 

31

11

 

1–2 mm

35 (8)

88

NA

0.3 (0.11–0.85)

 

21

14

 

25

10

 

2–10 mm

121 (27)

85

NA

0.33 (0.14–0.77)

 

81

35

 

94

26

 

10–50 mm

155 (34)

80

NA

0.4 (0.17–0.95)

 

100

50

 

112

43

 

 > 50 mm

46 (10)

80

NA

0.3 (0.11–0.81)

 

29

17

 

36

9

 

Missing

22 (5)

          

miR126 in tumor

    

 < 0.001

      

Low

300 (66)

75

NA

1.00

       

High

140 (31)

88

NA

0.43 (0.29–0.64)

       

Missing

12 (3)

          

miR126 in stroma

    

0.005

      

Low

341 (75)

76

NA

1.00

       

High

109 (24)

88

NA

0.46 (0.29–0.71)

       

Missing

2 (0)

          
  1. ECOG, eastern cooperative oncology group.